KJ Biosciences LLC
  • About
  • Technologies and Product Candidates
    • Novel Nanoparticle Protein Technology
    • Universal Influenza Vaccine
    • Nanoparticle Conjugate Vaccine
  • Research Reagents and Services
    • Specialty Influenza Virus Antibodies
    • Specialty Carrier Proteins
    • How to Order
  • Contact

Novel Nanoparticle Protein Technology


Picture
Dual-domain nanoparticle fusion protein (DDNFP)

Nanoparticles are playing an increasingly important role in facilitating development of vaccines and diagnostic products. The company has strong expertise in proprietary use of natural nanoparticle proteins found exclusively in bacteria and archaea. DDNFP is based on a novel nanoparticle protein which uniquely allows simultaneous fusion and surface presentation at both N-and C-termini along with nanoparticle formation. This feature greatly enhances the antigen presentation and is not readily available with other nanoparticle protein carriers.  It can be particularly useful for vaccines and diagnostic products by allowing simultaneous and separate presentation of two or more different domains or antigens.

(c) 2025 KJ Biosciences LLC. All rights reserved.